Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
260.5 USD | -0.20% |
|
+3.78% | +36.10% |
Jul. 03 | Jerome Powell did it again | ![]() |
Jul. 03 | JPMorgan Chase Raises Price Target on Alnylam Pharmaceuticals to $248 From $160 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+36.10% | 33.02B | |
+22.10% | 47.07B | |
+46.45% | 42.06B | |
-3.12% | 39.98B | |
-6.30% | 27.9B | |
+18.71% | 27.63B | |
+46.15% | 14.37B | |
+44.52% | 13.45B | |
+0.19% | 12.03B | |
-8.55% | 10.86B |
- Stock Market
- Equities
- ALNY Stock
- News Alnylam Pharmaceuticals, Inc.
- Alnylam Pharmaceuticals Insider Sold Shares Worth $370,747, According to a Recent SEC Filing